Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
Grupo Español de Investigación en Cáncer de Ovario
Masonic Cancer Center, University of Minnesota
Institut Bergonié
University of Surrey
Imperial College London
Imperial College London
Institut Bergonié
PharmaMar
GlaxoSmithKline
Assiut University
Abramson Cancer Center at Penn Medicine
Boston Scientific Corporation
MedSIR
Imperial College London
Memorial Sloan Kettering Cancer Center
Fenway Community Health
Amgen
Amgen
Sandoz
Merck Sharp & Dohme LLC
University of Arkansas
Instituto Oncologico Luis Razetti